Functional alterations of mesenteric small resistance arteries in Milan hypertensive and normotensive rats

Hypertension Research

Volumn 32, Issue 7, 2009, Pages 581-585

  Rizzoni, Damiano ^a   Castellano, Maurizio ^a   Porteri, Enzo ^a   Giacchè, Mara ^a   Ferrari, Patrizia ^b   Cusi, Daniele ^c   De Ciuceis, Carolina ^a   Boari, Gianluca E M ^a   Rosei, Enrico Agabiti ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Prassis Sigma Tau Research Institute   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA ADDUCIN; NORADRENALIN;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY RESISTANCE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HEART LEFT VENTRICLE MASS; HYPERTENSION; MALE; MESENTERIC ARTERY; MORPHOLOGY; NONHUMAN; RAT; RAT STRAIN; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CALMODULIN-BINDING PROTEINS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HYPERTENSION; MALE; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; RATS; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 67650527141     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.57     Document Type: Article

References (32)

1. Staessen JA, Bianchi G. Adducin and hypertension. Pharmacogenomics 2005; 6: 665-669.
2. Bianchi G, Ferrari P, Staessen JA. Adducin polymorphism. Detection and impact on hypertension and related disorders. Hypertension 2005; 45: 331-340
3. Castellano M, Barlassina C, Muiesan ML, Beschi M, Cinelli A, Rossi F, Rizzoni D, Cusi D, Agabiti-Rosei E. Alpha-adducin gene polymorphism and cardiovascular phenotypes in a general population. J Hypertens 1997; 15(12 Part 2): 1707-1710.
4. Sarzani R, Cusi D, Salvi F, Barlassina C, Macciardi F, Pietrucci F, Cola G, Catalini R, Dal Fiume C, Dessì-Fulgheri P, Rappelli A. The 460Trp allele of alpha-adducin increases carotid intima-media thickness in young adult males. J Hypertens 2006; 24: 697-703.
5. Balkestein EJ, Wang JG, Struijker-Boudier HA, Barlassina C, Bianchi G, Birkenhäger WH, Brand E, Den Hond E, Fagard R, Herrmann SM, Van Bortel LM, Staessen JA. Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian population. J Hypertens 2002; 20: 1551-1561.
6. Balkestein EJ, Staessen JA, Wang JG, van Der Heijden-Spek JJ, Van Bortel LM, Barlassina C, Bianchi G, Brand E, Herrmann SM, Struijker-Boudier HA. Carotid and femoral artery stiffness in relation to three candidate genes in a White population. Hypertension 2001; 38: 1190-1197.
7. Laurent S. Genotype interactions and intima-media thickness. J Hypertens 2002; 20: 1477-1478.
8. Perticone F, Sciacqua A, Barlassina C, Del Vecchio L, Signorello MC, Dal Fiume C, Andreozzi F, Sesti G, Cusi D. Gly460Trp alpha-adducin gene polymorphism and endothelial function in untreated hypertensive patients. J Hypertens 2007; 25: 2234-2239.
9. Tripodi G, Florio M, Ferrandi M, Modica R, Zimdahl H, Hubner N, Ferrari P, Bianchi G. Effect of Add1 gene transfer on blood pressure in reciprocal congenic strains of Milan rat. Biochem Biophys Res Commun 2004; 324: 562-568.
10. Mulvany MJ, Halpern W. Contractile properties of small resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19-26.
11. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978; 43: 854-864.
12. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti-Rosei E. Vascular structural and functional alterations before and after the development of hypertension in SHR. Am J Hypertens 1994; 7: 193-200.
13. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti Rosei E. Delayed development of hypertension after short-term nitrendipine treatment. Hypertension 1994; 24: 131-139.
14. Rizzoni D, Porteri E, Piccoli A, Castellano M, Bettoni G, Muiesan ML, Pasini G, Guelfi D, Mulvany MJ. Agabiti Rosei Effects of losartan and enalapril on small artery structure in hypertensive rats. Hypertension 1998; 32: 305-310.
15. Vecchione C, Frata L, Rizzoni D, Notte A, Poulet R, Porteri E, Frati G, Guelfi D, Trimarco V, Mulvany MJ, Agabiti Rosei E, Trimarco B, Cotecchia S, Lembo G. Cardiovascular influences of a1B-adrenergic receptor in mice. Circulation 2002; 105: 1700-1707.
16. Ferrari P, Ferrandi M, Valentini G, Manunta P, Bianchi G. Targeting ouabain and adducin-dependent mechanism of hypertension and cardiovascular remodeling as a novel pharmacological approach. Med Hypotheses 2007; 68: 1207-1314.
17. Ferrari P, Ferrandi M, Valentini G, Bianchi G. Rostafuroxin: An ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adduc-independent hypertension. Am J Physiol Regul Integr Comp Physiol 2006; 290: R529-R535. Review.
18. Je HD, Gallant C, Leavis PC, Morgan KG. Caveolin-1 regulates contractility in differentiated vascular smooth muscle. Am J Physiol Heart Circ Physiol 2004; 286: H91-H98.
19. Forte A, Esposito S, De Feo M, Galderisi U, Quarto C, Esposito F, Renzulli A, Berrino L, Cipollaro M, Agozzino L, Cotrufo M, Rossi F, Cascino A. Stenosis progression after surgical injury in Milan hypertensive rat carotid arteries. Cardiovasc Res 2003; 60: 654-663.
20. Morishige K, Shimokawa H, Eto Y, Kandabashi T, Miyata K, Matsumoto Y, Hoshijima M, Kaibuchi K, Takeshita A. Adenovirus-mediated transfer of dominant-negative Rhokinase induces a regression of coronary arteriosclerosis in pigs in vivo. Arterioscler Thromb Vasc Biol 2001; 21: 548-554.
21. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990; 70: 921-971.
22. Heagerty AM, Aalkjaaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual process of remodeling and growth. Hypertension 1993; 21: 391-397.
23. De Ciuceis C, Rizzoni D, Agabiti Rosei C, Porteri E, Boari GEM, Agabiti Rosei E. Remodelling of small resistance arteries in essential hypertension. High Blood Press 2006; 13: 1-6.
24. Mulvany MJ, Persson AE, Andresen J. No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure. J Hypertens 1991; 9: 589-593.
25. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Cinelli A, Zulli R, Agabiti- Rosei E. Prolonged effects of short-term fosinopril on blood pressure and vascular morphology and function in rats. Am J Hypertens 1997; 10: 1034-1043.
26. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Cinelli A, Agabiti Rosei E. Effects of low and high doses of fosinopril on the structure and function of resistance arteries. Hypertension 1995; 26: 118-123.
27. Mulvany MJ. Small artery remodeling and significance in the development of hypertension. News Physiol Sci 2002; 17: 105-109.
28. Cooper IV G. Basic determinants of myocardial hypertrophy: A review of molecular mechanisms. Annu Rev Med 1997; 48: 13-23.
29. Barlassina C, Perticone F, Gelfi C, Dal Fiume C, Ruello A, Sciacqua A. The 460Trp allele of Add1 activates ROS production and causes endothelial dysfunction in essential hypertension. J Hypertens 2005; 23 (Suppl 2): S263 (abstract).
30. Tripodi G, Valtorta F, Torielli L, Chieregatti E, Salardi S, Trusolino L. Hypertension associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest 1996; 97: 2815-2822.
31. Tripodi MG, Valtorta F, Torielli L, Chieregatti E, Salardi S, Trusolino L, Menegon A, Ferrari P, Marchisio PC, Bianchi G. Hypertension associated point mutations in the adducin α and β subunits affect actin cytoskeleton and ion transport. J Clin Invest 1996; 97 2815-2822.
32. Rizzoni D, Porteri E, Guelfi D, Piccoli A, Castellano M, Pasini G, Muiesan ML, Mulvany MJ, Agabiti Rosei E. Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension 2000; 35: 931-935.